Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.00 0.29% 1,381.00 1,372.00 1,375.00 1,403.00 1,370.00 1,386.00 193,482 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 259.9 56.4 22.0 62.8 2,839

Abcam Share Discussion Threads

Showing 776 to 796 of 1000 messages
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
DateSubjectAuthorDiscuss
22/1/2015
17:43
Abcam is featured in today's ADVFN podcast. To listen to the podcast click here> http://bit.ly/ADVFN0113 In today's podcast: - Chris Oil, financial writer and city investor will be chatting about a well known name who could be back in fashion. Chris on Twitter is @ChrisOil - And Rodney Hobson, a financial speaker, writer and author of investment books including Shares Made Simple, the beginner's guide to the stock market. Rodney on Twitter is @RodneyHobson - The micro and macro news - Plus the broker forecasts Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin    
jeffcranbounre
22/1/2015
17:24
Abcam may well have it's ups and downs.... Look at the chart and it is mainly up. They do however have unique capability in a market which has long term grant funding... For me this is a safer bet in a downturn than gold but also okay generally. The fact that the bod take a view of future markets and invest in a company that they can add value to is positive. What may cost in the short term is wise in the long term. They could easily have made no progress by cutting overheads to a minimum in search of short term share price reward. The acquisition is further evidence of bod that understands the future market and can close a deal. Strip out currency and the growth is stunning. If you look forward then those currency trends may well reverse.
richscotsman
22/1/2015
11:11
Have they also got russian problems? Oxford Instruments warns on profits due to tightened Russia sanctions Link to Abcams offical distributor in russia hxxp://www.almabion.ru/ (Abcam is their top supplier hxxp://www.pivotalscientific.com/distributors-europe/listing/almabion Not looking good
christmasworker
22/1/2015
09:17
CW Singer said sell back in July, when the price was 360. I learned a long time ago that financial analysts know nothing about Big Pharma, let alone the likes of ABCAM. IC were saying sell AZN on the basis of pipeline for years, when I was buying between £18-£20 (so was the company). Now they are saying buy, on the basis of the pipeline, and I am selling at £47+ (could get caught out if Pfizer come back, but I believe that their aattention is elsewhere) I think that ABC is geometrically geared to its market place, and that terms like break-even are not relevant to an acquisition like Firefly. It's probably worth it for profile! I bet the management, years ago, on ABC. Tipsters like CR and analysts come and go. If they do drop to 360p again I shall bet the farm (and rich will increase as well) - my Mum will open her purse too. Six months or so later the tipsters will spring out of their boxes:-) apad
apad
21/1/2015
21:01
Apad My only criticism of the abcam bod so far is that I had to get a biotech geek to translate the rns...
richscotsman
21/1/2015
20:42
hxxp://www.cambridge-news.co.uk/Abcam-announces-18-5m-buy-American-firm-Firely/story-25900575-detail/story.html
hastings
21/1/2015
19:43
Maybe you can feed some jargon back, rich :-) I expect the share price to drift back - but bloody 'ell this is a good company. Should I break my 10% rule! apad
apad
21/1/2015
19:41
They give grants to scientists rich …hence enthusiasm :-) However they get grants too: Firefly BioWorks received a $500,000 grant from the Massachusetts Life Science Center to further develop its multiplex platform for biomarker detection. The award was made through the Center’s Small Business Matching Grant program, which is designed to provide additional support to companies that have already received Phase 2 SBIR funding from federal agencies. Firefly says the new funds will facilitate the increase of production capacity, introduction of new products, and expansion of its team. “Our company is at an inflection point and these funds will accelerate our commercialization and the expansion of our customer base,” remarks Davide Marni, Ph.D., co-founder and CEO. Firefly is exploiting its platform technology to develop instrument-independent assays for life sciences and clinical diagnostics. The firm’s flagship FirePlex™ assay, launched in March, is a custom 25-plex miRNA assay that can be carried out on standard cytometers. The entire miRNA detection process can be used directly on cell lysate and tissue digest and requires just three steps; hybridize, label, and report, Firefly explains. The hybridization step binds miRNA targets to target-specific probes attached to FirePlex hydrogel particles. Labeling ligates a universal biotinylated adapter to the captured targets, and a fluorescent reporter is then bound to the universal adapter to enable miRNA detection in a flow cytometer. One of the key features of the hydrogel particles is that they enable capture of the target molecules throughout the entire particle, not just on the surface, which Firefly claims enables expression results that are nearly independent of sample amount and generates a linear response curve below 100 attomoles of target.
apad
21/1/2015
19:04
I spoke to a stem cell scientist about firefly and she seems enthused.... Mentioned the interaction of junk dna and rna being huge potential growth sectors in research... The rest of the conversation could have been double Dutch as far as I am concerned as she went into science geek babble.... Rich
richscotsman
21/1/2015
13:57
funding constraints in educational and research establishments May get downgrade as they say "After an initial period of modest investment, Firefly is expected to generate attractive returns in the longer term." looks like a profit downgrade with a coat on
christmasworker
21/1/2015
08:28
Strong sales imo - and now the currency is moving more in ABC's favour too. All imo/dyor etc. CR
cockneyrebel
21/1/2015
07:26
Hope so, my Mum wants to buy more :-) apad
apad
21/1/2015
07:06
Can see the market disappointed with todays lukewarm news Overall we expect total revenue growth for the period to be 13.8% on a constant currency basis and following the adverse rates of exchange seen during the period compared to H1 2013/14, growth on a reported basis to be 7.7%. Gross margin percentages at the product and geographic levels are expected to be broadly flat and in line with management's expectations, whilst the impact of the mix means that overall they are likely to be slightly less than those seen in the same period last year.
christmasworker
16/1/2015
20:31
If anything is wrong here news wise, this will shed 200p
christmasworker
16/1/2015
14:31
through resistance now richscotchman - £5 area looks the next test imo. Bit of news for you out today: http://www.pharmabiz.com/NewsDetails.aspx?aid=86101&sid=2 Abcam inks partnership with IMCB to develop high-quality immunoassays for life science research All imo/dyor etc CR
cockneyrebel
16/1/2015
10:28
i think it will hit the upward trend line anywhere around the 466 - 462 on this mini pullback and then resume its upward movement and get the next resistance around 495 IMHO
barefoot141
14/1/2015
15:51
Broken out of an up-trend resistance line - should mean a steeper rise imo: free stock charts from uk.advfn.com
cockneyrebel
11/1/2015
10:16
Apad... Can't blame you for finding warmer climes.... A few trees down and a couple of slates off the roof but as it is not long since the last storm anything too flimsy was already gone! Looking forward to the trading update as ever.... Rich
richscotsman
09/1/2015
14:29
trading update 16-23rd Jan in the last 3 years. CR
cockneyrebel
09/1/2015
10:54
The model looks as sound as a bell, rich. It always felt right - a management type couldn't set up a business to compete. Small companies in the same niche look too risky. It seems to me that their intellectual property just gets more valuable with time - and more difficult to compete against. I've bought 11 times since 2010 and the April purchase was bigger than the previous ten put together. This tends to be my way of working - I call the portfolio a stairway and ABC is on the top step now. My rules prevent me buying more as it's now 7.5% of the portfolio. This thread's a pleasure (also quite entertaining to see CR promoting the share). Are you a rich scotsman suffering the hurricane force winds off the Hebrides, or have you moved to warmer climes? Force 12! We tend to get the fringes of those weather systems in Jersey. apad
apad
09/1/2015
10:10
..... now I am a long term investor so not too worried about peaks and troughs.... but I really do like the look of the chart just now.... must be heading into the £5-6 zone soon.....
richscotsman
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
Your Recent History
LSE
ABC
Abcam
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191214 00:23:24